Risk of Cardiovascular Events Among Patients Initiating Efavirenz-Containing Versus Efavirenz-Free Antiretroviral Regimens

DOI: 10.1093/ofid/ofw061

Keywords: antiretroviral agents, efavirenz, human immunodeficiency virus, major adverse cardiovascular events

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text